Surg Endosc27 May 2025
Key findings reveal that specific patient characteristics, including race, body mass index (BMI), diabetes, chronic obstructive pulmonary disease (COPD), gastroesophageal reflux disease (GERD), and therapeutic anticoagulation, are linked to elevated 30-day readmission rates following metabolic surgery. Notably, black and Hispanic patients showed increased odds of…
Surg Laparosc Endosc Percutan Tech17 May 2025
In a study involving 8,433 bariatric surgery patients, ursodeoxycholic acid (UDCA) significantly lowered cholecystectomy incidents. Among the 5,061 patients not receiving UDCA, 2.9% underwent cholecystectomy, compared to just 0.5% of the 3,372 patients treated with 600 mg of UDCA daily for six months. Notably, the…
Int J Surg8 May 2025
A systematic review and meta-analysis involving 138,001 patients compared same-day discharge (SDD) laparoscopic sleeve gastrectomy (LSG) with inpatient (IP) procedures. Findings revealed SDD resulted in significantly fewer emergency room visits versus IP (odds ratio 1.52). No significant differences were found in readmission (odds ratio 1.48)…
Obes Surg20 Apr 2025
A propensity score-matched analysis of 406 patients revealed that concomitant laparoscopic sleeve gastrectomy (LSG) with hiatal hernia repair (HHR) significantly improves outcomes for gastroesophageal reflux disease (GERD) compared to LSG alone. While operative time was longer with HHR, the only notable difference in complications was…
Metabolic and Bariatric Surgery11 Apr 2025
Bariatric surgery significantly improves survival outcomes among patients with obesity and cirrhosis, showing observed survival of 9.09 years compared to 8.23 years for lifestyle interventions. The incremental cost-effectiveness ratios were $18,679 for sleeve gastrectomy and $44,704 for gastric bypass in cirrhosis cohorts, proving cost-effective when…
Obes Surg10 Apr 2025
The study reveals that 41.3% of metabolic and bariatric surgeons experience diminished professional confidence due to serious complications, with 39.7% affected at home. Feelings of guilt, anxiety, and sleep disorders were reported by 53.7%, 53.7%, and 44.6% of respondents, respectively. Key barriers to seeking help…
Gastrointest Endosc2 Apr 2025
A global expert consensus defined standardized practices for Endoscopic Sleeve Gastroplasty (ESG) utilizing a modified Delphi method. Six experts, after three survey rounds, achieved 100% agreement on six cognitive skill statements and high consensus on 21 technical skill statements. Key procedural elements emphasized were starting…
Metabolic and Bariatric Surgery30 Mar 2025
Recent advancements in obesity treatment highlight new pipeline agents that effectively match weight loss results of surgery. Notably, GLP-1 analogs not only reduce weight but also improve obesity-related health issues. However, significant gaps remain, with alternative treatment options needed to address muscle mass loss and…
J Hepatol26 Mar 2025
The study demonstrates that simultaneous liver transplant and sleeve gastrectomy leads to significant long-term weight loss, improved diabetes and hypertension outcomes, and lower rates of allograft steatosis compared to liver transplant alone. Over a follow-up period, ltsg patients, starting with a higher average BMI, showed…
JAMA Surg1 Mar 2025
After a decade of follow-up in the SM-BOSS trial, Roux-en-Y gastric bypass (RYGB) demonstrated superior efficacy in achieving percentage excess body mass index loss compared to sleeve gastrectomy (SG), with means of 65.9% and 56.1% respectively. Though total weight loss showed no significant difference, patients…